Cadila gets USFDA approval to market 4 generic products
Zydus Cadila has received final approvals from the US health regulator, to market four generic products in America. The approvals received are for Olanzapine tablets in strengths...
Tag : 4%
Suven Life secures 4 product patents
Suven Life Sciences has secured four product patents. The company has secured one product patent each from India, Singapore, South Korea and Israel corresponding to the new chemical entities...
SRF Q4 profit slumps 4% at Rs.124 crore
SRF Ltd has posted a 4% decline in its consolidated net profit at Rs.124 crore, for the quarter ended March 31,2018. The company’s net profit...
HDFC to sell over 4% stake in HDFC AMC via IPO
HDFC Ltd will sell over 4% stake in HDFC AMC, which is its asset management arm via an initial public offer (IPO). In a regulatory...